RESEARCH FOR CLINICAL CHARACTERISTICS AND PLASMA DOPAMINE CONCENTRATIONS IN SCHIZOOPHRENIC PATIENTS

Bùi Phương Thảo1,, Đỗ Xuân Tĩnh2
1 Mai Huong Daycare Psychiatric Hospital
2 Military Hospital 103

Main Article Content

Abstract

Objectives: Clinical characteristics and plasma dopamine levels in schizophrenic patients. Subjects and Metholds: Descriptive reaserch, cross-sectional; clinical characteristics and plasma dopamine levels in 72 patients with schizophrenic inpatient were treated at the Department of Psychiatry -  Military Hospital 103 from August 2020 to January 2021. Results: Common age group is from 21-30 years old, accounting for 37.5%; male 58.33%; female 41.67%. Schizophrenia is a paranoid, accounting for 87,50%. There are 1 or more types of auditory hallucination in schizophrenic patients, accounting for 83,33%, commentary auditory (66,67%), auditory hallucination as a conversion symptom (61.67%). There are 1 or more types of paranoia in schizophrenic patients accounting for 94,44%, paranoia of being harmed (76,47%), paranoia of being spying on (51,47%). Common symptoms: lazy in work and study (86,11%), emotional explosion (72,22%), forgetfulness (81.94%), slow-paced thinking, intermittently thinking (77,78%). The mean plasma dopamine concentration of the patient 1st time was 73,09±40,83 pg/ml, the mean plasma dopamine concentration of the patient 2nd time was 27,91±19,13pg/ml and the mean plasma dopamine concentration of the control group was 26,55±12,32pg/ml. The difference in plasma dopamine concentration between the 1st and 2nd test; between the first test and the control group was statistically significant; The difference between the second test and the control group was not statistically significant. Conclusion: Schizophrenia is most common in people aged 21-30 years, no difference in gender. The main manifestations are auditory hallucinations, paranoia, emotional disturbances, attention-memory disorders, and thought-form disorders. The mean plasma dopamine concentration of patients with schizophrenia was higher than that of the control group and decreased to normal after 3 weeks of treatment.

Article Details

References

1. Sadock B.J., Sadock V.A. (2008). “Schizophrenia”, Concise textbook of clinical psychiatry, Third edition, William and Wilkins, pp. 156-177.
2. Trịnh Văn Anh (2017). Nghiên cứu đặc điểm dịch tễ học lâm sàng rối loạn tâm thần ở bệnh nhân tự sát. Luận án tiến sỹ, Học viện Quân Y, Hà Nội.
3. Nguyễn Thanh Bình (2010). Nghiên cứu đặc điểm lâm sàng và nồng độ Dopamine huyết tương ở bệnh nhân tâm thần phân liệt thể paranoid. Luận án tiến sỹ, Học viện Quân Y, Hà Nội.
4. Rao M.L., Gross G., Halaris A. et al. (1993). “Hyperdopaminergia in schizophreniform psychosis: a chronobiological study”, Psychiatry Res, May, 47(2), pp. 187-203.
5 . Dávila R., Zumárraga M., Basterreche N. et al. (2007). “Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms”, Psychiatry Res., 30; 151(1-2), pp. 163-168.
6. Z.J.Zhang, M.Peet, C.N.Ramchand et al., (2001). “Plasma homovanillic acid in untreated schizophrenia — relationship with symptomatology and sex”, Journal of Psychiatric Research, Volume 35, Issue 1, pp. 23-28.